Rotavirus Vaccines Market Size, Share & Growth Graph by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Rotavirus Vaccines Market Size Analysis

Global Rotavirus Vaccines Market Introduction
By Vaccine Type
1. Introduction
  1. Vaccine Type By Value
2. Monovalent Rotavirus Vaccines 
  1. By Value
3. Pentavalent Rotavirus Vaccines 
  1. By Value
4. Broad-Spectrum Rotavirus Vaccines 
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Injectable
  1. By Value
4. By Distribution Channel
  1. By Value
5. Hospital & Retail Pharmacies
  1. By Value
6. Government Suppliers
  1. By Value
7. Other Distribution Channels
  1. By Value

North America Market Analysis

Introduction
By Vaccine Type
1. Introduction
  1. Vaccine Type By Value
2. Monovalent Rotavirus Vaccines 
  1. By Value
3. Pentavalent Rotavirus Vaccines 
  1. By Value
4. Broad-Spectrum Rotavirus Vaccines 
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Injectable
  1. By Value
4. By Distribution Channel
  1. By Value
5. Hospital & Retail Pharmacies
  1. By Value
6. Government Suppliers
  1. By Value
7. Other Distribution Channels
  1. By Value
U.S.
1. By Vaccine Type
  1. Introduction
    1. Vaccine Type By Value
  2. Monovalent Rotavirus Vaccines 
    1. By Value
  3. Pentavalent Rotavirus Vaccines 
    1. By Value
  4. Broad-Spectrum Rotavirus Vaccines 
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Injectable
    1. By Value
  4. By Distribution Channel
    1. By Value
  5. Hospital & Retail Pharmacies
    1. By Value
  6. Government Suppliers
    1. By Value
  7. Other Distribution Channels
    1. By Value
Canada

Europe Market Analysis

Introduction
By Vaccine Type
1. Introduction
  1. Vaccine Type By Value
2. Monovalent Rotavirus Vaccines 
  1. By Value
3. Pentavalent Rotavirus Vaccines 
  1. By Value
4. Broad-Spectrum Rotavirus Vaccines 
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Injectable
  1. By Value
4. By Distribution Channel
  1. By Value
5. Hospital & Retail Pharmacies
  1. By Value
6. Government Suppliers
  1. By Value
7. Other Distribution Channels
  1. By Value
U.K.
1. By Vaccine Type
  1. Introduction
    1. Vaccine Type By Value
  2. Monovalent Rotavirus Vaccines 
    1. By Value
  3. Pentavalent Rotavirus Vaccines 
    1. By Value
  4. Broad-Spectrum Rotavirus Vaccines 
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Injectable
    1. By Value
  4. By Distribution Channel
    1. By Value
  5. Hospital & Retail Pharmacies
    1. By Value
  6. Government Suppliers
    1. By Value
  7. Other Distribution Channels
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Vaccine Type
1. Introduction
  1. Vaccine Type By Value
2. Monovalent Rotavirus Vaccines 
  1. By Value
3. Pentavalent Rotavirus Vaccines 
  1. By Value
4. Broad-Spectrum Rotavirus Vaccines 
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Injectable
  1. By Value
4. By Distribution Channel
  1. By Value
5. Hospital & Retail Pharmacies
  1. By Value
6. Government Suppliers
  1. By Value
7. Other Distribution Channels
  1. By Value
China
1. By Vaccine Type
  1. Introduction
    1. Vaccine Type By Value
  2. Monovalent Rotavirus Vaccines 
    1. By Value
  3. Pentavalent Rotavirus Vaccines 
    1. By Value
  4. Broad-Spectrum Rotavirus Vaccines 
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Injectable
    1. By Value
  4. By Distribution Channel
    1. By Value
  5. Hospital & Retail Pharmacies
    1. By Value
  6. Government Suppliers
    1. By Value
  7. Other Distribution Channels
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Vaccine Type
1. Introduction
  1. Vaccine Type By Value
2. Monovalent Rotavirus Vaccines 
  1. By Value
3. Pentavalent Rotavirus Vaccines 
  1. By Value
4. Broad-Spectrum Rotavirus Vaccines 
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Injectable
  1. By Value
4. By Distribution Channel
  1. By Value
5. Hospital & Retail Pharmacies
  1. By Value
6. Government Suppliers
  1. By Value
7. Other Distribution Channels
  1. By Value
UAE
1. By Vaccine Type
  1. Introduction
    1. Vaccine Type By Value
  2. Monovalent Rotavirus Vaccines 
    1. By Value
  3. Pentavalent Rotavirus Vaccines 
    1. By Value
  4. Broad-Spectrum Rotavirus Vaccines 
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Injectable
    1. By Value
  4. By Distribution Channel
    1. By Value
  5. Hospital & Retail Pharmacies
    1. By Value
  6. Government Suppliers
    1. By Value
  7. Other Distribution Channels
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Vaccine Type
1. Introduction
  1. Vaccine Type By Value
2. Monovalent Rotavirus Vaccines 
  1. By Value
3. Pentavalent Rotavirus Vaccines 
  1. By Value
4. Broad-Spectrum Rotavirus Vaccines 
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Injectable
  1. By Value
4. By Distribution Channel
  1. By Value
5. Hospital & Retail Pharmacies
  1. By Value
6. Government Suppliers
  1. By Value
7. Other Distribution Channels
  1. By Value
Brazil
1. By Vaccine Type
  1. Introduction
    1. Vaccine Type By Value
  2. Monovalent Rotavirus Vaccines 
    1. By Value
  3. Pentavalent Rotavirus Vaccines 
    1. By Value
  4. Broad-Spectrum Rotavirus Vaccines 
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Injectable
    1. By Value
  4. By Distribution Channel
    1. By Value
  5. Hospital & Retail Pharmacies
    1. By Value
  6. Government Suppliers
    1. By Value
  7. Other Distribution Channels
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Rotavirus Vaccines Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

GSK plc
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Merck & Co., Inc.
Serum Institute of India Pvt. Ltd.
Sanofi S.A.
Bharat Biotech International Ltd.
Sinovac Biotech Ltd.
Bio Farma
Biological E Limited
Lanzhou Institute of Biological Products Co., Ltd.
Shanghai Institute of Biological Products Co., Ltd.
Hualan Biological Engineering Inc.
Panacea Biotec Ltd.
Zydus Cadila
Indian Immunologicals Limited
Pfizer Inc.
Novartis AG

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment